Please assess the completion status of the following clinical trial:

Trial Title: Therapeutic Drug Monitoring of Voriconazole

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients who were 16 years of age or older~* receiving voriconazole in order to treat invasive fungal infections or for empirical use~Exclusion Criteria:~* who experienced the serious side effect of voriconazole~* were hypersensitive to azoles~* had an aminotransferase, bilirubin, or alkaline phosphatase level higher than five times the upper limit of normal

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- non-TDM of voriconazole (Type: NO_INTERVENTION): conventional dose
- TDM of voriconazole (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).